KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Operating Expenses (2016 - 2025)

Ionis Pharmaceuticals has reported Other Operating Expenses over the past 12 years, most recently at $8.0 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $8.0 million for Q4 2025, up 107.81% from a year ago — trailing twelve months through Dec 2025 was $15.9 million (up 41.85% YoY), and the annual figure for FY2025 was $15.9 million, up 132675.0%.
  • Other Operating Expenses for Q4 2025 was $8.0 million at Ionis Pharmaceuticals, up from $2.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for IONS hit a ceiling of $756.8 million in Q4 2022 and a floor of $1.1 million in Q3 2024.
  • Median Other Operating Expenses over the past 5 years was $3.0 million (2021), compared with a mean of $71.2 million.
  • Biggest five-year swings in Other Operating Expenses: soared 18417.16% in 2021 and later tumbled 99.6% in 2023.
  • Ionis Pharmaceuticals' Other Operating Expenses stood at $610.9 million in 2021, then rose by 23.89% to $756.8 million in 2022, then tumbled by 99.6% to $3.1 million in 2023, then increased by 25.09% to $3.8 million in 2024, then skyrocketed by 107.81% to $8.0 million in 2025.
  • The last three reported values for Other Operating Expenses were $8.0 million (Q4 2025), $2.3 million (Q3 2025), and $4.2 million (Q2 2025) per Business Quant data.